Hematology/Oncology/BMT

While people with sickle cell disease have better outcomes in the United States and other Western countries, progress in treating the disease has been slow moving.

An emerging, innovative metric could radically change childhood health policy.

Adolescents and young adults with cancer have unique needs that may explain their plateau in survival rates, despite improved survival rates in other age groups.

A recent decision may define the future of virotherapy’s role in the clinical treatment of cancer.

Funding challenges, operational complexity and poor visibility threaten the field of human tissue biobanking. How sustainable are biorepositories?